title: European consensus table 2006 on botulinum toxin for children with cerebral palsy.
abstract: An interdisciplinary group of experienced botulinum toxin users and experts in the field of movement disorders was assembled, to develop a consensus on best practice for the treatment of cerebral palsy using a problem-orientated approach to integrate theories and methods. The authors tabulated the supporting evidence to produce a condensed but comprehensive information base, pooling data and experience from nine European countries, 13 institutions and more than 5500 patients. The consensus table summarises the current understanding regarding botulinum toxin treatment options in children with CP.
authors.affiliation: Department of Paediatric Neurology and Developmental Neurology, Dr. von Hauner's Children's Hospital, University of Munich, Lindwurmstr. 4, D-80337 Munich, Germany. florian.heinen@med.uni-muenchen.de
authors.forename: Florian
authors.initials: F
authors.lastname: Heinen
authors.forename: Guy
authors.initials: G
authors.lastname: Molenaers
authors.forename: Charlie
authors.initials: C
authors.lastname: Fairhurst
authors.forename: Lucinda J
authors.initials: LJ
authors.lastname: Carr
authors.forename: Kaat
authors.initials: K
authors.lastname: Desloovere
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Chaleat Valayer
authors.forename: Edith
authors.initials: E
authors.lastname: Morel
authors.forename: Antigone S
authors.initials: AS
authors.lastname: Papavassiliou
authors.forename: Kristina
authors.initials: K
authors.lastname: Tedroff
authors.forename: S
authors.initials: S
authors.lastname: Ignacio Pascual-Pascual
authors.forename: Günther
authors.initials: G
authors.lastname: Bernert
authors.forename: Steffen
authors.initials: S
authors.lastname: Berweck
authors.forename: Guiseppe
authors.initials: G
authors.lastname: Di Rosa
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Kolanowski
authors.forename: Ingeborg
authors.initials: I
authors.lastname: Krägeloh-Mann
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000592:standards / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000592:standards / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D005060:Europe; D006801:Humans
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins